Novartis Ag (NVS) Inventory (2009 - 2026)
Novartis Ag (NVS) posted Inventory of $6.2 billion for Q2 2026, down 0.78% sequentially from $6.3 billion in Q4 2025, and down 1.38% YoY from $6.3 billion in Q2 2025.
Novartis Ag (NVS) Inventory (2009 - 2026) Analysis & Trends
Novartis Ag has reported Inventory for 18 years, with the latest figure at $6.2 billion in Q2 2026.
- Quarterly Inventory fell 1.38% year-over-year to $6.2 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.2 billion (down 1.38% YoY) and the FY2025 annual result came in at $6.3 billion, up 9.54% from the prior year.
- Inventory retreated to $6.2 billion in Q2 2026 per NVS's latest filing, from $6.3 billion in the prior quarter.
- Over five years, Inventory peaked at $8.2 billion in Q2 2023 and troughed at $5.7 billion in Q4 2024.
- A 5-year average of $6.5 billion and a median of $6.3 billion in 2025 frame the typical range for Inventory.
- The sharpest annual moves came in 2023 and 2024: Inventory rose 19.59% in 2023, then slumped 30.15% in 2024.
- Over 5 years, Inventory stood at $7.2 billion in 2022, then declined by 17.59% to $5.9 billion in 2023, then fell by 3.21% to $5.7 billion in 2024, then grew by 9.54% to $6.3 billion in 2025, then declined by 0.78% to $6.2 billion in 2026.
- According to Business Quant data, Inventory over the past three periods registered $6.2 billion, $6.3 billion, and $6.3 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 15.14 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.13 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.21 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 6.22 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.93 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.22 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.95 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 9.95 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.43 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 12.93 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.22 Bn |
| Dec 31, 2025 | 6.27 Bn |
| Jun 30, 2025 | 6.31 Bn |
| Dec 31, 2024 | 5.72 Bn |
| Jun 30, 2024 | 5.75 Bn |
| Dec 31, 2023 | 5.91 Bn |
| Jun 30, 2023 | 8.23 Bn |
| Dec 31, 2022 | 7.18 Bn |
| Jun 30, 2022 | 6.88 Bn |
| Dec 31, 2021 | 6.67 Bn |
| Jun 30, 2021 | 7.11 Bn |
| Dec 31, 2020 | 84.00 Mn |
| Sep 30, 2020 | 84.00 Mn |
| Jun 30, 2020 | 84.00 Mn |
| Mar 31, 2020 | 84.00 Mn |
| Dec 31, 2019 | 195.00 Mn |
| Jun 30, 2019 | 6.00 Mn |
| Mar 31, 2019 | 6.00 Mn |
| Dec 31, 2018 | 6.96 Bn |
| Sep 30, 2018 | 186.00 Mn |